Clinical, Biological and Histological Pulmonary and Renal Damage Associated With the SARS-CoV-2 Syndrome in Patients Admitted in ICU

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

320 participants

Study Classification

OBSERVATIONAL

Study Start Date

2020-04-27

Study Completion Date

2020-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Renal damage in patients hospitalized for ARDS in the ICU can also be related to multiple causes including, but not limited to, the consequences of hemodynamic fluctuations in these patients or the use of nephrotoxic drugs responsible for acute post-ischemic or toxic tubular necrosis. Frequently observed abnormalities of cioagumation may also have a potential impact on renal structures, particularly glomerular capillaries.

The researchers wish to characterize and phenotype the renal impairment of patients hospitalized in intensive care with tables of severe Covid19 infections in ARDS: clinical, biological and histological (by performing post-mortem biopsies).

Translated with www.DeepL.com/Translator (free version)

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Clinical Features and Risk Factors Associated With Worse Outcome in Patients Hospitalized for Covid-19 Pneumonia

NCT04362345

Covid-19

UNKNOWN

Impact of Inflammation Biomarkers on the Acute Respiratory Distress Syndrome (ARDS) Definition

NCT01161901

Acute Respiratory Distress Syndrome

COMPLETED

Pulmonary Inflammation in COVID-19 ARDS

NCT04935450

ARDS Due to Disease Caused by Severe Acute Respiratory Syndrome Coronavirus 2 COVID-19 Acute Respiratory Distress Syndrome

UNKNOWN

Early Biological and Mechanical Profiling in Sepsis-Associated ARDS

NCT07281911

Acute Hypoxemic Respiratory Failure Sepsis ARDS (Acute Respiratory Distress Syndrome)

NOT_YET_RECRUITING

Lung Ultrasound in COVID-19 Patients

NCT04487769

Covid19 Ultrasound ARDS

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Acute Respiratory Distress Syndrome

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients over 18 years of age
* Diagnosed Covid-19 by RT PCR
* Hospitalized in intensive care for management of complications related to Covid-19 from March 1, 2020 to April 20, 2020
* Patient not having expressed his or her opposition, after information, to the re-use of his or her data for the purposes of this research.